Opinion: PARP inhibitors in cancer—what do we still need to know?
Sign Up to like & getrecommendations! Published in 2022 at "Open Biology"
DOI: 10.1098/rsob.220118
Abstract: PARP inhibitors (PARPi) have been demonstrated to exhibit profound anti-tumour activity in individuals whose cancers have a defect in the homologous recombination DNA repair pathway. Here, we describe the current consensus as to how PARPi… read more here.
Keywords: opinion parp; parp; cancer still; still need ... See more keywords